Joel Greenblatt Ani Pharmaceuticals Inc Transaction History

Gotham Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.53 - $68.82 $165,113 - $194,141	-2,821 Reduced 36.4%	4,929 $313,000
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $82,329 - $105,859	-1,519 Reduced 16.39%	7,750 $535,000
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $202,918 - $272,515	4,165 Added 81.6%	9,269 $511,000
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $256,629 - $329,769	5,104 New	5,104 $296,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $594,947 - $815,614	-14,451 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $80,007 - $107,794	-1,511 Reduced 9.47%	14,451 $817,000
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $899,937 - $1.09 Million	15,962 New	15,962 $1.07 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.